These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37809459)

  • 1. The m6A reader YTHDC1-mediated lncRNA CTBP1-AS2 m6A modification accelerates cholangiocarcinoma progression.
    Jin Z; Liu Y
    Heliyon; 2023 Sep; 9(9):e19816. PubMed ID: 37809459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SP1-induced upregulation of lncRNA CTBP1-AS2 accelerates the hepatocellular carcinoma tumorigenesis through targeting CEP55 via sponging miR-195-5p.
    Liu LX; Liu B; Yu J; Zhang DY; Shi JH; Liang P
    Biochem Biophys Res Commun; 2020 Dec; 533(4):779-785. PubMed ID: 32988587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA CTBP1-AS2 Facilitates Gastric Cancer Progression via Regulating the miR-139-3p/MMP11 Axis.
    Yang Y; Gao M; Li Y; Li M; Ma Q
    Onco Targets Ther; 2020; 13():11537-11547. PubMed ID: 33204108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory Mechanism of lncRNA CTBP1-AS2 in Nasopharyngeal Carcinoma Cell Proliferation and Apoptosis via the miR-140-5p/BMP2 Axis.
    Huang B; Li Y; Deng Z; Lan G; Si Y; Zhou Q
    Protein Pept Lett; 2022; 29(7):621-630. PubMed ID: 35894463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. lncRNA CTBP1-AS2 promotes proliferation and migration of glioma by modulating miR-370-3p-Wnt7a-mediated epithelial-mesenchymal transition.
    Li Y; Zong J; Zhao C
    Biochem Cell Biol; 2020 Dec; 98(6):661-668. PubMed ID: 33150795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of long noncoding RNA VIM-AS1 and CTBP1-AS2 expression in type 2 diabetes.
    Erfanian Omidvar M; Ghaedi H; Kazerouni F; Kalbasi S; Shanaki M; Miraalamy G; Zare A; Rahimipour A
    J Cell Biochem; 2019 Jun; 120(6):9315-9323. PubMed ID: 30506719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA CTBP1-AS2 is upregulated in osteoarthritis and increases the methylation of miR-130a gene to inhibit chondrocyte proliferation.
    Zhang H; Li J; Shao W; Shen N
    Clin Rheumatol; 2020 Nov; 39(11):3473-3478. PubMed ID: 32388751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA CTBP1-AS2 enhances cervical cancer progression via up-regulation of ZNF217 through sponging miR-3163.
    Yang S; Shi F; Du Y; Wang Z; Feng Y; Song J; Liu Y; Xiao M
    Cancer Cell Int; 2020; 20():343. PubMed ID: 32742190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. METTL3 promotes glycolysis and cholangiocarcinoma progression by mediating the m6A modification of AKR1B10.
    Cai J; Cui Z; Zhou J; Zhang B; Lu R; Ding Y; Hu H
    Cancer Cell Int; 2022 Dec; 22(1):385. PubMed ID: 36476503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA CTBP1-AS2 Promotes Cell Proliferation in Hepatocellular Carcinoma by Regulating the miR-623/Cyclin D1 Axis.
    Wang M; Zhao H
    Cancer Biother Radiopharm; 2020 Dec; 35(10):765-770. PubMed ID: 32522013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA CTBP1-AS2 sponges miR-216a to upregulate PTEN and suppress endometrial cancer cell invasion and migration.
    Wang QA; Yang Y; Liang X
    J Ovarian Res; 2020 Apr; 13(1):37. PubMed ID: 32293505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long noncoding RNA DLGAP1-AS2 facilitates cholangiocarcinoma progression via miR-505 and GALNT10.
    Liu Z; Pan L; Yan X; Duan X
    FEBS Open Bio; 2021 Feb; 11(2):413-422. PubMed ID: 33301605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of N6-Methyladenosine Regulators and m6A Reader YTHDC1-Mediated N6-Methyladenosine Modification Is Involved in Oxidative Stress in Human Aortic Dissection.
    Yin F; Liu K; Peng W; Jiang D; Zhang H; Guo P; Wu Y; Zhang X; Sun C; Wang Y; Wang H; Han Y
    Oxid Med Cell Longev; 2023; 2023():3918393. PubMed ID: 36819785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CTBP1-AS2 promoted non-small cell lung cancer progression via sponging the miR-623/MMP3 axis.
    Yang G; Zhang C
    Environ Sci Pollut Res Int; 2022 May; 29(25):38385-38394. PubMed ID: 35076836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulating Long Non-coding RNAs CTBP1-AS2 Inhibits Colorectal Cancer Development by Modulating the miR-93-5p/TGF-β/SMAD2/3 Pathway.
    Li Q; Yue W; Li M; Jiang Z; Hou Z; Liu W; Ma N; Gan W; Li Y; Zhou T; Yue W; Chen S
    Front Oncol; 2021; 11():626620. PubMed ID: 33937030
    [No Abstract]   [Full Text] [Related]  

  • 16. LncRNA CTBP1-AS2 alleviates high glucose-induced oxidative stress, ECM accumulation, and inflammation in diabetic nephropathy via miR-155-5p/FOXO1 axis.
    Wang G; Wu B; Zhang B; Wang K; Wang H
    Biochem Biophys Res Commun; 2020 Nov; 532(2):308-314. PubMed ID: 32868076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms of long chain non-coding RNA CTBP1-AS in regulation of invasion and migration of breast cancer cells.
    Cui HB; Geng CZ
    J Biol Regul Homeost Agents; 2019 May-Jun,; 33(3):773-785. PubMed ID: 31165609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial downregulation of nuclear m6A reader YTHDC1 promotes pulmonary vascular remodeling in sugen hypoxia model of pulmonary hypertension.
    Zheng H; Wu D; Chen X; He W; Hua J; Li Q; Ji Y
    Heliyon; 2024 Feb; 10(3):e24963. PubMed ID: 38318069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sp1-induced LncRNA CTBP1-AS2 is a novel regulator in cardiomyocyte hypertrophy by interacting with FUS to stabilize TLR4.
    Luo X; He S; Hu Y; Liu J; Chen X
    Cardiovasc Pathol; 2019; 42():21-29. PubMed ID: 31220774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. m
    Zheng H; Zhu M; Li W; Zhou Z; Wan X
    Liver Int; 2022 May; 42(5):1144-1157. PubMed ID: 35274813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.